Medicus Pharma Ltd. (NASDAQ: MDCX) (“Medicus” or the “Company”), a precision guided, biotech/life sciences company focused on advancing novel and potentially disruptive therapeutic assets, today ...

Medicus Pharma (NASDAQ:MDCX) has submitted a seamless Phase 2b/3 registration-intent protocol to the US Food and Drug ...

Medicus Pharma Ltd. had submitted an optimized seamless Phase 2b/3 registration-intent protocol to the U.S. Food and Drug Administration (?FDA?) for Teverelix®, its investigational, next generation, ...

Diabetes or hypertension was associated with poorer prostate cancer-specific survival among smokers with castration-resistant ...

Pluvicto just received a major expansion, marking a notable shift in prostate cancer care following the U.S. Food and Drug Administration’s (FDA) most recent approval. The FDA has approved Pluvicto ...

A new term has come for metastatic prostate cancer treatment at Fox Chase Cancer Center. 'Theranostics' combines diagnostics ...

Add Yahoo as a preferred source to see more of our stories on Google. A targeted cancer drug niraparib, used in combination with hormone therapy, was found to reduce the risk of prostate tumor growth ...

Dr. Jamin Brahmbhatt is a urologist and robotic surgeon with Orlando Health and an assistant professor at the University of Central Florida’s College of Medicine. “How long do I have to live ?” When I ...

UNC Health Southeastern’s Gibson Cancer Center continues to redefine what cancer care can look like in a rural community.

The vast majority of people diagnosed with prostate cancer can expect to live long, full lives thanks to improved screening that catches the disease in its early and most treatable stages. But ...

I f prostate cancer has spread to other areas of your body, your doctor may recommend androgen deprivation therapy (ADT), which halts the production of androgen hormones, especially testosterone.

Texas A&M researchers are leading an NIH collaboration searching natural compounds for new ways to treat advanced prostate ...